|
Advanced Medical Solutions Group PLC on Wednesday reported strong growth in its Surgical business which underpinned a 29% increase in annual sales. The Cheshire, England-based surgical dressings company said pretax profit leapt 81% to £17.8 million in 2025 from £9.8 million the year prior. Diluted earnings per share improved 39% to 4.52 pence from 3.25p, or by 12% to 11.74p from 10.45p on an adjusted basis. Adjusted earnings before interest, taxes, depreciation and amortisation increased 20% to £49.9 million from £40.2 million, at a margin of 21.8%, down from 22.6%. Revenue grew 29% to £228.9 million from £177.5 million the year before, with growth of 36% in Surgical and 8.9% in Advanced Woundcare. ‘The strength of our expanded portfolio, our growing global presence, and the commercial synergies across the group, have all contributed to another year of robust growth,’ said Chief Executive Chris Meredith. ‘As we look ahead, we are strongly positioned to continue building on this foundation and accelerate our long term growth,’ Meredith continued. AMS said it enters 2026 with ‘strong commercial momentum, a clearer operating platform and a robust pipeline that supports multiyear growth.’ Continued strong growth in Surgical and modest growth in Woundcare is expected, as longterm supply agreements take effect. Strong cash generation and disciplined capital allocation are expected to support further deleveraging, the firm added. AMS said it is ‘confident’ of delivering full year 2026 revenue and Ebitda in line with current market expectations of £245.3 million and £55.2 million respectively. AMS proposed an increased final dividend of 2.01p per share, up from 1.83p a year ago, bringing the total dividend to 2.86p per share, up 10% from 2.60p. Shares in the company rose 4.7% to 206.00p each in London on Wednesday morning. Copyright 2026 Alliance News Ltd. All Rights Reserved.
|
